Disease | rosacea |
Symptom | C0041834|erythema |
Sentences | 9 |
PubMedID- 26022994 | The face values: global perceptions survey aimed primarily to assess the impact of facial erythema associated with rosacea on the subconscious perceptions and initial reactions of others, including those affected by the condition. |
PubMedID- 25505014 | Brimonidine gel (mirvaso-galderma) became available in february of this year for the symptomatic treatment of facial erythema associated with rosacea in adults.1 here, we review the evidence on brimonidine gel and consider its place in the management of erythema associated with rosacea. |
PubMedID- 26112098 | The aim of these two studies was to determine the optimal dose regimen for the treatment of moderate to severe erythema associated with rosacea, and based on the results the concentration of 0.5% brimonidine gel was selected for phase iii evaluation . |
PubMedID- 24506775 | Methods: a pharmacokinetic study was conducted to compare intraindividual systemic exposures after dermal application of bt gel (0.07%, 0.18% and 0.5%) under maximal use conditions in patients with moderate-to-severe facial erythema associated with rosacea, and administration of bt ophthalmic solution 0.2%. |
PubMedID- 23388530 | At the same time, a substantial reduction of erythema in patients with rosacea were not revealed. |
PubMedID- 25897253 | In two adults with refractory erythema and flushing associated with rosacea, oxymetazoline nasal solution 0.05% applied to facial skin demonstrated significant decreased erythema one hour after application that progressed to dramatic improvement within 3 hours and remained throughout the day25 (figure 6). |
PubMedID- 26099423 | Laser and light-based therapies for erythema in rosacea were effective (low-quality evidence). |
PubMedID- 22768356 | erythema and flushing associated with rosacea remains an uncomfortable and socially embarrassing problem for patients. |
PubMedID- 25074756 | Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema. |
Page: 1